Cadrenal Therapeutics (CVKD) Amortizatization of Intangibles (2022 - 2023)
Cadrenal Therapeutics (CVKD) posted Amortizatization of Intangibles of $13567.0 for Q1 2023, down 63.93% sequentially from $37611.0 in Q4 2022, and up 440.95% YoY from $2508.0 in Q1 2022.
Cadrenal Therapeutics (CVKD) Amortizatization of Intangibles (2022 - 2023) Analysis & Trends
Cadrenal Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $13567.0 in Q1 2023.
- Quarterly Amortizatization of Intangibles rose 440.95% year-over-year to $13567.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $13567.0 (down 79.72% YoY) and the FY2023 annual result came in at $13567.0, down 79.72% from the prior year.
- Amortizatization of Intangibles retreated to $13567.0 in Q1 2023 per CVKD's latest filing, from $37611.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $37611.0 in Q4 2022 and troughed at $2508.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13,567.00 |
| Mar 31, 2023 | 13,567.00 |
| Dec 31, 2022 | 37,611.00 |
| Dec 31, 2022 | 37,611.00 |
| Sep 30, 2022 | 18,470.00 |
| Sep 30, 2022 | 18,470.00 |
| Jun 30, 2022 | 8,324.00 |
| Jun 30, 2022 | 8,324.00 |
| Mar 31, 2022 | 2,508.00 |
| Mar 31, 2022 | 2,508.00 |